It has been reported that the PET scan provides additional information for the diagnosis of extrahepatic HCC [9,14] and is an important tool for surveillance of distant metastasis in patients with unexplained AFP elevation after HCC treatment [15]. Here, AFP is linked to hepatocellular carcinoma.